Article Versions Notes

Herrera-Gómez RG, Grecea M, Gallois C, Boige V, Pautier P, Pistilli B, Planchard D, Malka D, Ducreux M, Mir O. Safety and Efficacy of Bevacizumab in Cancer Patients with Inflammatory Bowel Disease. Cancers. 2022; 14(12):2914. https://doi.org/10.3390/cancers14122914

Herrera-Gómez, Ruth Gabriela, Miruna Grecea, Claire Gallois, Valérie Boige, Patricia Pautier, Barbara Pistilli, David Planchard, David Malka, Michel Ducreux, and Olivier Mir. 2022. "Safety and Efficacy of Bevacizumab in Cancer Patients with Inflammatory Bowel Disease" Cancers 14, no. 12: 2914. https://doi.org/10.3390/cancers14122914

Herrera-Gómez, R. G., Grecea, M., Gallois, C., Boige, V., Pautier, P., Pistilli, B., Planchard, D., Malka, D., Ducreux, M., & Mir, O. (2022). Safety and Efficacy of Bevacizumab in Cancer Patients with Inflammatory Bowel Disease. Cancers, 14(12), 2914. https://doi.org/10.3390/cancers14122914